Date: Wednesday, December 9
Time: 12:00-1:00PM EST
Space is limited.
Reserve your Webinar seat now at:
https://www1.gotomeeting.com/register/668144112
Please mention priority code: P1506W2TWITTERBLOG
About the webinar:
The FDA Social Media and Internet Public Hearing November 12-13, 2009 posed many questions for the pharmaceutical and biotech industries. Hear impressions of the event in a live interview with Jonathan Richman, Director of Business Development, Bridge Worldwide (Hearing Speaker) and Mel Halkyard, Global eCapabilities Director, Eli Lilly (Hearing Attendee) .
What You Will Learn:
* Potential policy and regulatory actions from the FDA as a result of the hearing
* Major obstacles and challenges presented by the industry due to lack of guidance
* Solutions suggested by the industry to address current issues with internet and social media
About the Speakers:
About the webinar:
The FDA Social Media and Internet Public Hearing November 12-13, 2009 posed many questions for the pharmaceutical and biotech industries. Hear impressions of the event in a live interview with Jonathan Richman, Director of Business Development, Bridge Worldwide (Hearing Speaker) and Mel Halkyard, Global eCapabilities Director, Eli Lilly (Hearing Attendee) .
What You Will Learn:
* Potential policy and regulatory actions from the FDA as a result of the hearing
* Major obstacles and challenges presented by the industry due to lack of guidance
* Solutions suggested by the industry to address current issues with internet and social media
About the Speakers:
Jonathan Richman, Director of Business Development
Bridge Worldwide
Author, Dose of Digital
Jonathan provides strategic direction and leadership for our clients with a concentration in healthcare. A big part of Jonathan’s role is helping solve clients’ business challenges by finding the right solutions among all of the many choices available to today’s brand managers. From social networking to relationship marketing to channels such as mobile and complex back-end technology platforms, Jonathan helps clients sift through the clutter and hype to find the best options for their brands.
Prior to joining Bridge Worldwide, Jonathan worked at AstraZeneca Pharmaceuticals for more than 11 years, holding positions in sales, training, sales leadership, and marketing in diverse disease areas including cardiovascular, oncology, asthma, and neuroscience.
Jonathan is a well-known and widely regarded thought leader in pharma digital strategy. He is the author of the popular industry blog, Dose of Digital, which provides insights on digital marketing in pharma and healthcare. It is one of the most read blogs of its kind and is one of the top marketing blogs according to the AdAge Power 150 (currently ranked at #133). Jonathan is a regular speaker at major pharma marketing meetings and conventions, including eight engagements scheduled for the second half of 2009 alone. He was also recently invited to speak at the FDA public hearings on social media in pharma; he was one of only sixty people given the opportunity.
Jonathan earned his Bachelor of Science degree in Molecular Biology from Tulane University. He earned a Master of Business Administration with a marketing concentration from the University of Phoenix.
Mel Halkyard, Global e-Capabilities Director
Eli Lilly & Company
Mel has over 18 years of pharmaceutical industry experience. She has spent the majority of her career leading transformational efforts to build or improve sales and marketing capabilities at Lilly. She has developed and implemented brand strategies in the US operations as well as globally. Most recently, Mel has been responsible for accelerating the development of global e-capabilities at Lilly, most notably launching a Global e-Center of Excellence which has been charged with the governance of the e-channel, including social media.
|
Share this article with your social network, just click below to share now!
|
|
|
